Technical Analysis for ALVR - AlloVir, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Historical ALVR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Shooting Star Candlestick | Bearish | 4.34% | |
| 180 Bearish Setup | Bearish Swing Setup | 4.34% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 4.34% | |
| MACD Bullish Signal Line Cross | Bullish | 4.34% | |
| Pocket Pivot | Bullish Swing Setup | 1.79% | |
| Oversold Stochastic | Weakness | 1.79% | |
| Pocket Pivot | Bullish Swing Setup | 3.48% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 20 DMA Resistance | 1 day ago |
| Rose Above 20 DMA | 1 day ago |
| Up 5% | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Outside Day | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/31/2021
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cells Gene Therapy Manufacturing Process Cell Biology Proprietary Technology Cell Therapy Viruses Immunity Viral Disease Virus Viral Diseases Zoonoses Shimon Slavin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cells Gene Therapy Manufacturing Process Cell Biology Proprietary Technology Cell Therapy Viruses Immunity Viral Disease Virus Viral Diseases Zoonoses Shimon Slavin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 48.96 |
| 52 Week Low | 16.8 |
| Average Volume | 231,742 |
| 200-Day Moving Average | 29.81 |
| 50-Day Moving Average | 20.80 |
| 20-Day Moving Average | 18.85 |
| 10-Day Moving Average | 17.99 |
| Average True Range | 1.08 |
| ADX | 28.29 |
| +DI | 16.34 |
| -DI | 24.94 |
| Chandelier Exit (Long, 3 ATRs) | 18.71 |
| Chandelier Exit (Short, 3 ATRs) | 20.04 |
| Upper Bollinger Bands | 21.03 |
| Lower Bollinger Band | 16.68 |
| Percent B (%b) | 0.48 |
| BandWidth | 23.08 |
| MACD Line | -0.84 |
| MACD Signal Line | -0.94 |
| MACD Histogram | 0.1039 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.60 | ||||
| Resistance 3 (R3) | 20.46 | 19.71 | 20.29 | ||
| Resistance 2 (R2) | 19.71 | 19.24 | 19.78 | 20.18 | |
| Resistance 1 (R1) | 19.23 | 18.95 | 19.47 | 19.37 | 20.08 |
| Pivot Point | 18.48 | 18.48 | 18.60 | 18.55 | 18.48 |
| Support 1 (S1) | 18.00 | 18.01 | 18.24 | 18.14 | 17.42 |
| Support 2 (S2) | 17.25 | 17.72 | 17.32 | 17.32 | |
| Support 3 (S3) | 16.77 | 17.25 | 17.21 | ||
| Support 4 (S4) | 16.91 |
